Tiffini Reedy
Adult Health · Fall River, MANPI 1891128708
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,257 of the $58,116 with a category attached, or 84.8%. Teva Pharmaceuticals USA, Inc. accounts for 95.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $55,328, more than ten times the $562 reported in 2021. Among adult health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $264.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$55K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$882
- Johnson & Johnson$794
- Otsuka America Pharmaceutical, Inc.$656
- Alkermes, Inc.$153
- E.r. Squibb & Sons, L.L.C.$70
- plus $88 from 2 others
What the payments were for
- Consulting fees$3301%
- Speaking & faculty fees$49,25785%
- Travel & lodging$3,5926%
- Food & beverage$4,6618%
- Education$2760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 110 | $55,475 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $882 |
| Johnson & Johnson | 41 | $794 |
| Otsuka America Pharmaceutical, Inc. | 28 | $656 |
| Alkermes, Inc. | 2 | $153 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Neurocrine Biosciences, Inc. | 3 | $67 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$53,375
- ARISTADA$500
- ARISTADA INITIO$125
- AUSTEDO$120
- ABILIFY ASIMTUFII$120
- ABILIFY MAINTENA$120
- CAPLYTA$107
How this compares
$58,116 in reported general payments places this provider in the 95th percentile of 671 adult health providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 141 | $443,081 |
| AustedoDeutetrabenazine | 67 | $367,706 |
| Invega TrinzaPaliperidone Palmitate | 13 | $119,409 |
| Abilify MaintenaAripiprazole | 23 | $67,030 |
| Abilify AsimtufiiAripiprazole | 12 | $64,657 |
| Clozapine | 317 | $10,360 |
| Aripiprazole | 111 | $8,533 |
| Divalproex Sodium ErDivalproex Sodium | 181 | $4,760 |
| Atomoxetine Hcl | 50 | $2,335 |
| Olanzapine | 128 | $2,249 |
| Prazosin Hcl | 96 | $1,642 |
| Lithium Carbonate ErLithium Carbonate | 75 | $1,431 |
| Risperidone | 134 | $1,429 |
| Perphenazine | 12 | $1,424 |
| Benztropine Mesylate | 122 | $1,334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $794 | $562,490154 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $55,475 | $367,70667 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Abilify Asimtufii | $656 | $131,68735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 671 adult health providers in Massachusetts.
Other adult health in Fall River
- Ann-Marie McCabeFall River$6K
- Erika RebelloFall River$5K
- Rachel ResendesFall River$5K
- Kevin BlanchardFall River$4K
- Kristen CarrollFall River$4K
- Kathleen ElliottFall River$4K
- Susan NavarroFall River$3K
- Jennifer GillisFall River$3K
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.